Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Linaclotide shows preclinical potential for bladder hyperactivity

May 25, 2016

Interim phase II data for bardoxolone methyl show improvement in renal function

May 24, 2016

Roche patents disclose CYP11B2 inhibitors

May 13, 2016

Overactive bladder candidate DA-8010 may have reduced potential for dry mouth

May 13, 2016

Ono Pharmaceutical introduces voltage-gated channel activators

May 12, 2016

OPKO Health and Vifor Fresenius Medical Care enter Rayaldee agreement

May 10, 2016

Significant efficacy seen with SER-120 nasal spray in phase III nocturia study

May 10, 2016

Boehringer Ingelheim Pharma develops aldosterone synthase inhibitors

April 29, 2016

FDA accepts OPKO's resubmitted NDA for calcifediol

April 28, 2016

FDA grants fast track designation for recAP in acute kidney injury

April 27, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...